Successful treatment of juvenile xanthogranuloma using bevacizumab

Noy Ashkenazy, Christopher R. Henry, Ashkan M. Abbey, Craig A. McKeown, Audina M. Berrocal, Timothy G. Murray

Research output: Contribution to journalArticlepeer-review

20 Scopus citations


Juvenile xanthogranuloma (JXG) is an uncommon non-Langerhans cell histiocytic disorder that occurs predominantly in infants. Traditional treatment of ocular JXG involves the administration of topical or local corticosteroids. We treated 2 children with JXG refractory to local corticosteroid therapy with off-label intraocular bevacizumab. To our knowledge, this is the first report of successful use of bevacizumab for ocular JXG.

Original languageEnglish (US)
Pages (from-to)295-297
Number of pages3
JournalJournal of AAPOS
Issue number3
StatePublished - Jun 2014

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Ophthalmology


Dive into the research topics of 'Successful treatment of juvenile xanthogranuloma using bevacizumab'. Together they form a unique fingerprint.

Cite this